Tag: long-acting rFVIII (BAY 94-9027)
Bayer to invest more than 500 million euros for haemophilia A products manufacturing
Bayer, Germany’s biggest pharmaceutical company, has announced that it will invest more than 500 million euros in its Wuppertal and Leverkusen manufacturing sites to...
Featured Article
APS Industrial expands regional footprint with Control Technologies acquisition
APS Industrial (APS) is expanding its regional presence through the acquisition of Albury-based Control Technologies, a move the industrial products supplier said will strengthen its local service capability and support further investment in warehousing, stockholding and technical support.
